President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals ...
Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation ...
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
President Donald Trump has nominated Kennedy to be the secretary of the U.S. Department of Health and Human Services, which ...
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
Popular weight loss drugs like ... been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers, the Biden administration said ...
The U.S. Food and Drug Administration (FDA ... See the 10 stocks » However, the Centers for Medicare and Medicaid Services (CMS) could soon throw a monkey wrench into Novo Nordisk's momentum.
along with another program that would see Medicare pay less for drugs that receive accelerated approval from the Food and Drug Administration. The cell- and gene-therapy program, meanwhile ...
Medicare beneficiaries are expected to ... different formulations of the drug semaglutide, approved by the Food and Drug Administration at different times — as one class. Drug giant Novo Nordisk ...